A new method for quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells

L. Homolya, Z. Holló, M. Müller, E. B. Mechetner, B. Sarkadi

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

A rapid, functional and quantitative diagnostic method for the estimation of the P-glycoprotein (P-gp)-dependent multidrug resistance is required in the clinical treatment of human tumours, as chemotherapy protocols and resistance-reversin, agents could be applied accordingly. In the present work, by using a calcein accumulation method in combination with immunorecognition and drug-resistance studies, a new method is described for the quantitative estimation of the expression and function of the multidrug transporter. MDR1-transfected and drug-selected tumour cell lines with various levels of drug resistance were examined. The expression of P-gp and its cell-surface appearance were assessed by quantitative immunoblotting and by immunofluorescence cytometry. The transport function of the P-gp was assessed by measuring the extrusion of calcein acetoxymethyl ester (AM) with fluorometry and flow cytometry, while in parallel experiments drug resistance was directly examined in cell survival assays. The MDR1 activity factor (MAF), calculated from the calcein AM extrusion assay, is demonstrated to provide a reliable quantitative measure for MDR1 specific activity, reflecting cellular drug resistance. This relatively simple and rapid new functional P-gp assay surpasses the formerly used techniques in both sensitivity and reproducibility.

Original languageEnglish
Pages (from-to)849-855
Number of pages7
JournalBritish journal of cancer
Volume73
Issue number7
DOIs
Publication statusPublished - Jan 1 1996

Keywords

  • Calcein
  • Multidrug resistance activity factor
  • Multidrug resistance in cancer
  • P-glycoprotein

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'A new method for quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells'. Together they form a unique fingerprint.

  • Cite this